SIREN : 379793698
MEDICOS IZERNORE is a French company founded 35 years ago, specialized in the sector Fabrication d'emballages en matières plastiques. Based in IZERNORE (01580), this company of category PME shows in 2024 a revenue of 10.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 10 103 345 € | 13 707 055 € | N/C | 10 069 383 € | 7 815 914 € | 9 818 312 € | N/C | N/C |
| Net income | -218 216 € | 355 374 € | 10 798 € | 337 957 € | 297 973 € | 432 367 € | 70 596 € | 241 653 € |
| EBITDA | 378 961 € | 1 136 957 € | N/C | 509 987 € | 338 172 € | 589 927 € | N/C | N/C |
| Net margin | -2.2% | 2.6% | N/C | 3.4% | 3.8% | 4.4% | N/C | N/C |
In 2024, MEDICOS IZERNORE achieves revenue of 10.1 M€. Revenue is growing positively over 8 years (CAGR: +0.5%). Significant drop of -26% vs 2023. After deducting consumption (2.6 M€), gross margin stands at 7.5 M€, i.e. a rate of 75%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 379 k€, representing 3.8% of revenue. Warning negative scissor effect: despite revenue change (-26%), EBITDA varies by -67%, reducing margin by 4.5 pts. This reflects costs rising faster than revenue. The operating margin remains fragile, requiring cost vigilance. Net income is negative at -218 k€ (-2.2% of revenue), which will impact equity.
10 103 345 €
7 533 843 €
378 961 €
-133 549 €
-218 216 €
3.7%
The debt ratio (= Financial debt / Equity x 100) stands at 62%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 43%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 8.4 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 2.4% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
61.781%
42.72%
2.387%
8.387
In 2024, the debt ratio of MEDICOS IZERNORE (61.78) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of MEDICOS IZERNORE (42.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of MEDICOS IZERNORE (8.39) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
The liquidity ratio (= Current assets / Current liabilities) stands at 0.00. Alert: short-term debt exceeds current assets. Risk of payment difficulties without cash reinforcement. The interest coverage ratio (= EBIT / Interest expenses) is 32.3x. Operating income very largely covers interest expenses: high safety margin.
0.0
32.266
In 2024, the liquidity ratio of MEDICOS IZERNORE (0.00) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
In 2024, the interest coverage of MEDICOS IZERNORE (32.3x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 39 days. Excellent situation: suppliers finance 39 days of the operating cycle (retail model). WCR is negative (-59 days): operations structurally generate cash.
-1 649 371 €
0 j
39 j
0 j
-59 j
Based on 76 transactions of similar company sales
(all years),
the value of MEDICOS IZERNORE is estimated at
1 069 923 €
(range 487 796€ - 1 701 418€).
With an EBITDA of 378 961€, the sector multiple of 1.3x is applied.
The price/revenue ratio is 0.20x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 76 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare MEDICOS IZERNORE with other companies in the same sector:
Voir toutes les statistiques du secteur Fabrication d'emballages en matières plastiques
The revenue of MEDICOS IZERNORE in 2024 is 10.1 M€.
MEDICOS IZERNORE recorded a net loss in 2024.
The headquarters of MEDICOS IZERNORE is located in IZERNORE (01580), in the department Ain.
The tax return of MEDICOS IZERNORE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
MEDICOS IZERNORE operates in the sector Fabrication d'emballages en matières plastiques (NAF code 22.22Z). See the 'Sector positioning' section above to compare the company with its competitors.